International Journal of Advance in Molecular Engineering Original Research

Magnetic and Radioactive Nanoparticles for Improved Theranostics and AI Assisted Radiation Therapy

  1. Gizachew Diga Milki Department of Nanoscience and Technology, Jimma University

Abstract

Nanoparticles based therapeutic and theranostics technique is becoming an active area of research in nanomedicine. The sensitivity, biocompatibility, and stability of magnetic and radioactive nanoparticles determine their functionality. This research highlights the impacts of magnetic and radioactive nanoparticles on therapeutic techniques namely, cell therapy, gene therapy, and tissue regeneration. Then, it is intended to brief a principal role of these therapeutic techniques to envisage theranostics medicine and radiation therapy using the nanoparticles. Currently, a therapeutic and theranostics technique based on magnetic and radioactive nanoparticles is becoming an efficient treatment method for cancer and malignant disease. Moreover, the potential role of magnetic and radioactive nanoparticles in combined effect of diagnostics and imaging is seen. Customary, nanoparticles are investigated for magnetic fluid hyperthermia, magnetic resonance imaging, and theranostics. Moreover, they are good candidate of nano based drug delivery, nanocarriers, and nanozymes. The futures of such therapeutic technique have greater commitment on the AI assisted radiation therapy, theranostics, and drugs delivery system. In turn, the significance of theranostics medicine is investigated for the treatment of epidemics such as atherosclerosis, brain cancer, breast cancer, and cardiovascular disease.

Furthermore, ongoing studies reveal that nanoparticle-mediated therapies can be designed with surface modifications to achieve higher selectivity, minimizing systemic toxicity while maximizing therapeutic efficacy. Functionalization with ligands, antibodies, or peptides allows nanoparticles to actively target diseased cells, enhancing precision medicine approaches. Recent advances in multimodal imaging show that nanoparticles can simultaneously provide diagnostic information and therapeutic intervention, offering a real-time monitoring capability. This dual function not only accelerates the decision-making process for clinicians but also improves patient outcomes by enabling adaptive treatments. As research progresses, integration with machine learning and computational models is expected to refine nanoparticle design, optimize dosages, and predict therapeutic responses. Overall, magnetic and radioactive nanoparticles present a transformative pathway toward personalized, efficient, and safer healthcare systems, bridging the gap between conventional medicine and futuristic nanotheranostics.

Keywords

References (30)

  1. Farnaz Assa et al. A biotechnological perspective on the application of iron oxide nanoparticles Nano Research. 2016, 9(8): 2203–2225
  2. Geppert M and Himly M (2021). Iron Oxide Nanoparticles in Bioimaging: - An Immune Perspective. Front. Immunol. 12:688927. doi:10.3389/fimmu. 2021.688927
  3. Alphandéry, Edouard (2020). Iron oxide nanoparticles for therapeutic applications. Drug Discovery Today. 25 (1):141–149. DOI: htps://doi.org/10.1016/j.drudis. 2019. 09. 020
  4. GG De La Cruz et al. Interaction of nanoparticles with blood components and path of Physiological effects. 20 Dec 2017. doi:10.5772/intech open. 69386.
  5. M.Hosseini et al. Theranostics polymeric nanoparticles as a new approach in cancer therapy and diagnosis: a review. Materials today chemistry. 2023, V. 29, April 2023, 101400
  6. M. Niemeyer, C.A. Mirkin et al. Nanobiotechnolgy; concepts, applications, and perspectives. 2004. ISBN; 3. 527–30658–7
  7. Kosha J. Metha et al. Iron Oxide Nanoparticles in Mesenchymal Stem Cell Detection and Therapy. 2023 Stem Cell Reviews and Reports. 2022, 18:2234–2261
  8. Friedrich, R.P.; Cicha, I.; Alexiou, C. Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering. Nanomaterials. 2021, 11, 2337. https://doi.org/10.3390/ nano11092337
  9. Wu, S., Helal-Neto, E., Matos, S., Jafari, A., Kozempel, J., Silva, A., Serrano-Larrea, C., Junior, S. A., Ricci-Junior, E., Alexis, F., & Santos-Oliveira, R. (2020). Radioactive polymeric nanoparticles for biomedical application. Drug Delivery,27(1), 1544. https://doi.org/10.1080/10717544.2020. 1837296
  10. Uinarni H, Kadhum WR, Saleh RO, Alawadi A, Alnajar MJ, Shalaby NS, et al. Nanoparticle-based theranostics in nuclear medicine. Journal of Radioanalytical and Nuclear Chemistry. 2024;333(4):1661-1672. doi:10.1007/s10967-024-09432-7
  11. Chemosensors. doi:10.3390/chemosensors
  12. G. Cattaneo et al. Nanotechnology and human health: Risks and benefits. J. Appl. Toxicol. 2010; 30: 730–744.
  13. Holmannova D, Borsky P, Svadlakova T, Borska L, Fiala Z. Carbon Nanoparticles and Their Biomedical Applications. Applied Sciences. 2022;12(15):7865. doi:10.3390/app12157865
  14. Shende P, Gandhi S. Current strategies of radiopharmaceuticals in theranostic applications. Journal of Drug Delivery Science and Technology. 2021;64:102594. doi:10.1016/j.jddst.2021.102594
  15. Kumar P, Sharma V, Singh JP, Kumar A, Chahal S, Sachdev K, et al. Investigations on magnetic and electrical properties of Zn doped Fe2O3 nanoparticles and their correlation with local electronic structures. Journal of Magnetism and Magnetic Materials. 2019;489:165398. doi:10.1016/j.jmmm.2019.165398
  16. Shen et al. A novel software framework for magnetic particle le imaging reconstruction. Int J Imaging Syst Technol. 2022; 32: 11 19 –1132.
  17. Chen Y, Hou S. Application of magnetic nanoparticles in cell therapy. Stem Cell Research & Therapy. 2022;13(1). doi:10.1186/s13287-022-02808-0
  18. de La Torre LG, Sipoli CC, Oliveira AF, Eş I, Pessoa ACSN, Vitor MT, et al. Biopolymers for gene delivery applications. Biopolymer-Based Composites. 2017:289-323. doi:10.1016/b978-0-08-101914-6.00010-7
  19. Porteus MH, Connelly JP, Pruett SM. A Look to Future Directions in Gene Therapy Research for Monogenic Diseases. PLoS Genetics. 2006;2(9):e133. doi:10.1371/journal.pgen.0020133
  20. Herranz F, Almarza E, Rodriguez I, Salinas B, Rosell Y, Desco M, Bulte JW, Ruiz Cabello J, The applications of nanoparticles in gene therapy and magnetic resonance imaging. Microsco Res Tech. 2011 Jul. 74(7) 577- 91. Doi. 10.1002/ jemt. 20992.
  21. Canese, R.; Vurro, F.; Marzola, P. Iron Oxide Nanoparticles as Theranostics Agents in Cancer Immunotherapy. Nanomaterials. 2021, 11, 1950. https://doi.org/10.3390/ nano11081950
  22. Cushman TR, Gomez D, Kumar R, Likacheva A, Change JY, Candena AP, Paris S, and Welsh JW. Combining radiation plus immunotherapy to improve systemic immune response. Vol. 7, No-3, S 468-S 479. doi:10.21037/jtd. 2018. 01. 130
  23. Zhang Z, Liu X, Chen D, Yu J. Radiotherapy combined with immunotherapy: the dawn of cancer treatment. Signal Transduction and Targeted Therapy. 2022;7(1). doi:10.1038/s41392-022-01102-y
  24. Jiang C. et al. Application and progress of artificial intellegence in radiation therapy dose prediction.Clinical translation Radiation Oncology. 2024, 47(11):100792. Doi. 10.1016 /j.ctro.2024.100792.
  25. Senja Barthel et al. distinguished Metal Organic frame works. Crystal growth & design. 2018, 18, 3, 1738-1747. https://doi.org/10.1021/acs.cgd.7b01663.
  26. YW Khan. Molecular Medicine: from diagnosis to gene therapy. HKMJ. 1998, V. 4 (1) 98–102.
  27. Sri Amruthaa et al. Iron oxide nanoparticles for theranostics applications. Journal of Drug Delivery. Science and Technology. 2022; 70:103196
  28. Shakil MS, Hasan MA, Sarker SR. Iron Oxide Nanoparticles for Breast Cancer Theranostics. Current Drug Metabolism. 2019;20(6):446-456. doi:10.2174/1389200220666181122105043
  29. Nicole Jawerth (IAEA). Radiation and Radionuclide in medicine. Brief Overview of Nuclear Medicine and Radiotherapy. IAEA Bulletin. 2014, 55–4.
  30. Salbu, B., Kashparov, V., Lind, O. C., Garcia-Tenorio, R., Johansen, M. P., Child, D. P., Roos, P., & Sancho, C. (2018). Challenges associated with the behavior of radioactive particles in the environment. Journal of Environmental Radioactivity, 186, 101–115. https://doi.org/10.1016/j.jenvrad. 2017. 09. 001